Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00327288
Recruitment Status : Completed
First Posted : May 18, 2006
Last Update Posted : June 24, 2015
Information provided by (Responsible Party):
AmpliMed Corporation